Solidsoft Reply Limited
General Information
Identification Code: 152872452499-64
Website: [object Object]
Entity Form: Private limited company
Registration Category: Companies & groups
Registration Date: 1/16/2024
EP Accredited Number: 0
Mission & Interests
Goals: Solidsoft Reply is a technology company working in the healthcare and pharmaceutical sectors. We built and run the European Medicines Verification System used to verify approximately ten billion packs of medicine across the EU each year at 160,000 points of dispense. We operate national medicine verification systems in 14 EU countries. We build verification and traceability systems used across the world, together with healthcare-related systems focused on patient and medicine safety.
We work with non-profit organisations (UNICEF, USAID, GAVI, etc.), NGOs and the pharmaceutical industry combatting falsified and counterfeit medicines and reducing vaccine hesitancy in low- and middle-income countries.
Based in the UK, we are part of the Reply Group of technology companies headquartered in Milan in Italy. Reply operates across the EU and other regions of the world.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Food safety
- Public health
- Research and innovation
Levels of Interest:
- european
- global
- national
Activities
Main EU Legislative Proposals: Much of our work centres on two pieces of existing EU legislation:
Directive 2011/62/EU amending Directive 2001/83/EC. This is commonly known as the Falsified Medicines Directive (FMD)
Commission Delegated Regulation (EU) 2016/161 supplementing the FMD.
The EU is currently engaged in a major review of Directive 2001/83/EC with a view to introducing new and updated legislation which we expect to affect our work in medicines verification and traceability.
To date, our main communication with the EU is via the European Medicines Verification Organization (EMVO), a stakeholder non-profit organisation mandated by EU law and headquartered in Brussels. Going forward, we are currently planning to support and participate in the European Critical Medicines Alliance announced by the Health Emergency Preparedness and Response Authority (HERA) with a specific interest in addressing medicine shortages across the Union.
Communication Activities: In addition to our Web Site, we contribute regularly to thought leadership and discussion via Linked-In and attend various pharmaceutical events with a focus on medicine safety and verification.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: https://www.reply.com/solidsoft-reply02853022
Post Code: SW1W 0EB
City: London
Country: UNITED KINGDOM
Phone: [object Object]
EU Office
Address: https://www.reply.com/solidsoft-reply02853022
Post Code: SW1W 0EB
City: London
Country: UNITED KINGDOM
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 2
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 3
Members F T E: 0.44999998807907104
Structure
Structure Type: Structure
Is Member Of: We have a subsidiary company (Cluster Reply) https://www.reply.com/cluster-reply/en/
Organisation Members: GS1 Partner https://www.gs1uk.org/partner-finder